UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease

< UA
Jump to navigation Jump to search

Acute Coronary Syndrome Main Page

Unstable angina / NSTEMI Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Unstable Angina
Non-ST Elevation Myocardial Infarction

Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders

Epidemiology and Demographics

Risk Stratification

Natural History, Complications and Prognosis

Special Groups

Women
Heart Failure and Cardiogenic Shock
Perioperative NSTE-ACS Related to Noncardiac Surgery
Stress (Takotsubo) Cardiomyopathy
Diabetes Mellitus
Post CABG Patients
Older Adults
Chronic Kidney Disease
Angiographically Normal Coronary Arteries
Variant (Prinzmetal's) Angina
Substance Abuse
Cardiovascular "Syndrome X"

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Blood Studies
Biomarkers

Electrocardiogram

Chest X Ray

Echocardiography

Coronary Angiography

Treatment

Primary Prevention

Immediate Management

Anti-Ischemic and Analgesic Therapy

Cholesterol Management

Antitplatelet Therapy

Antiplatelet therapy recommendations
Aspirin
Thienopyridines
Glycoprotein IIb/IIIa Inhibitor

Anticoagulant Therapy

Additional Management Considerations for Antiplatelet and Anticoagulant Therapy

Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS

Mechanical Reperfusion

Initial Conservative Versus Initial Invasive Strategies
PCI
CABG

Complications of Bleeding and Transfusion

Discharge Care

Medical Regimen
Post-Discharge Follow-Up
Cardiac Rehabilitation

Long-Term Medical Therapy and Secondary Prevention

ICD implantation within 40 days of myocardial infarction

ICD within 90 days of revascularization

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease

CDC onUA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease

UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease in the news

Blogs on UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease

to Hospitals Treating UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease

Risk calculators and risk factors for UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

ACC / AHA Guidelines for Chronic Kidney Disease[1] (DO NOT EDIT)

Class I

"1. Creatinine clearance should be estimated in UA/NSTEMI patients and the doses of renally cleared medications should be adjusted according to the pharmacokinetic data for specific medications. (Level B)"

"2. Patients undergoing cardiac catheterization with receipt of contrast media should receive adequate preparatory hydration. (Level B)"
"3. Calculation of the contrast volume to creatinine clearance ratio is useful to predict the maximum volume of contrast media that can be given without significantly increasing the risk of contrast-associated nephropathy. (Level B)"

Class IIa

"1. An invasive strategy is reasonable in patients with mild (stage 2) and moderate (stage 3) CKD. (Level B) (There are insufficient data on benefit/risk of invasive strategy in UA/NSTEMI patients with advanced CKD [stages 4, 5].)"

References

  1. 2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR; et al. (2012). "2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 126 (7): 875–910. doi:10.1161/CIR.0b013e318256f1e0. PMID 22800849.

Template:WH Template:WS